Neutrophilic inflammation and CXC chemokines in patients with refractory asthma

International Archives of Allergy and Immunology

Volumn 149, Issue SUPPL. 1, 2009, Pages 87-93

  Kikuchi, Shinya ^a   Kikuchi, Izumi ^a   Takaku, Yotaro ^a   Kobayashi, Takehito ^a   Hagiwara, Koichi ^a   Kanazawa, Minoru ^a   Nagata, Makoto ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Interleukin 8; Neutrophils; Severe asthma

Indexed keywords

ALPHA CHEMOKINE; CXCL1 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8; SODIUM CHLORIDE;

ADULT; AIRWAY; ASTHMA; CELL COUNT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATORY CELL; MALE; NEUTROPHIL; PRIORITY JOURNAL; REFRACTORY ASTHMA; RESPIRATORY TRACT INFLAMMATION; SPUTUM;

ASTHMA; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-8; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; SPUTUM;

EID: 67650249518     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000211379     Document Type: Conference Paper

References (33)

1. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ: Bronchoscopic evaluation of severe asthma. Am J Resp Crit Care Med 1997;156:737-743.
2. Gibson PG, Simpson JL, Saltos N: Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001;119:1329-1336.
3. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ: Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999;353: 2213-2214.
4. Douwes J, Gibson P, Pekkanen J, Pearce N: Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002;57:643-648.
5. The ENFUMOSA Study Group: The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 20 03;22:470-477.
6. Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, Hunt LW, Gleich GJ: Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993;148:713-719.
7. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ: Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;16 0:1532-1539.
8. Shannon J, Ernst P, Yamauchi Y, Olivenstein R, Lemiere C, Foley S, Cicora L, Ludwig M, Hamid Q, Martin JG: Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008;133:420-426.
9. Kikuchi S, Nagata M, Kikuchi I, Hagiwara K, Kanazawa M: Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma. Int Arch Allergy Immunol 2005;137(suppl 1):7-11.
10. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA: Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor, and immune interferon. J Immunol 1986;137:1893-1896.
11. Smart SJ, Casale TB: TNF-α-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 1994;266:238-245.
12. Kikuchi S, Kikuchi I, Hagiwara K, Kanazawa M, Nagata M: Association of tumor necrosis factorαand neutrophilic inflammation in severe asthma. Allergol Int 2005;54:621-625.
13. Qiu Y, Zhu J, Bandi V, Guntupalli KK, Jeffery PK: Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax 2007;62:475-482.
14. Donninger H, Glashoff R, Haitchi HM, Syce JA, Ghildyal R, van Rensburg E, Bardin PG: Rhinovirus induction of the CXC chemokine epithelial-neutrophil activating peptide-78 in bronchial epithelium. J Infect Dis 2003;187:1809-1817.
15. Barnes PJ: New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 2007;119:1055-1062.
16. Shute JK, Vrugt B, Lindley IJ, Holgate ST, Bron A, Albers R: Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 1997;155:1877-1883.
17. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P: Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmatics. Am J Respir Crit Care Med 1999;159:487-494.
18. Gibson PG, Simpson JL, Saltos N: Heterogeneity of airway inflammation in patient asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001;119:1329-1336.
19. Pignatti P, Moscato G, Casarini S, Delmastro M, Poppa M, Brunetti G, Pisati P, Balbi B: Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways. J Allergy Clin Immunol 2005;115:88-94.
20. Kikuchi I, Kikuchi S, Kobayashi T, Hagiwara K, Kanazawa M, Nagata M: Eosinophil trans-basement migration induced by IL-8 and neutrophils. Am J Respir Cell Mol Biol 2006;34:760-765.
21. American Thoracic Society: Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000;162:2341-2351.
22. Keatings VM, Evans DJ, O'Connor BJ, Barnes PJ: Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 1997;52:372-374.
23. Pepe C, Foley S, Shannon J, Lemiere C, Olivenstein R, Ernst P, Ludwig MS, Martin JG, Hamid Q: Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 2005;116:544-549.
24. Fukakusa M, Bergeron C, Tulic MK, Fiset PO, Al Dewachi O, Laviolette M, Hamid Q, Chakir J: Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-γ-inducible protein 10 expression in asthmatic airway mucosa. J Allergy Clin Immunol 2005;115:280-286.
25. Jarjour NN, Gern JE, Kelly EA, Swenson CA, Dick CR, Busse WW: The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000;105:1169-1177.
26. Lummus ZL, Alam R, Bernstein JA, Bernstein DI: Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factorαby peripheral mononuclear cells of workers with occupational asthma. J Allergy Clin Immunol 1998;102:265-274.
27. Wos M, Sanak M, Soja J, Olechnowicz H, Busse WW, Szczeklik A: The presence of rhinovirus in lower airways of patients with bronchial asthma. Am J Respir Crit Care Med 2008;177:1082-1089.
28. Nakajima H, Gleich GJ, Kita H: Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 1996;156:4859-4866.
29. Smart SJ, Casale TB: Pulmonary epithelial cells facilitate TNF-α-induced neutrophil chemotaxis. A role for cytokine networking. J Immunol 1994;152:4087-4094.
30. Becker S, Quay J, Soukup J: Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 1991;147:4307-4312.
31. Burke SM, Issekutz TB, Mohan K, Lee PW, Shmulevitz M, Marshall JS: Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood 2008;111:5467-5476.
32. Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995;16:21-26.
33. Henson PM, Wenzel SE: Neutrophils and their mediators in asthma;in Busse WW, Holgate ST (eds): Asthma and Rhinitis. Oxford, Blackwell Science, 2000, pp 503-530.